Clinical TrialsSearch results
Number of results: 2963
Other
- JCOG1910: A Randomized Phase III Study of Chemoradiotherapy in Elderly Patients with Newly Diagnosed Glioblastoma
- glioblastoma
- ARAKAWA Yoshiki
- 2020-08-27
Other
- The renoprotective effects of ARB in patients with IgA nephropathy : multicenter,radomized trial
- IgA nephropathy
- ARB therapeutic society of IgA nephropathy
- 2006-03-31
Recruiting
- An open-label phase I study of AS-0141 in patients with advanced, metastatic, relapsed or refractory malignancies
- Solid tumors and hematologic malignancies (AML, MDS, DLBCL)
- Arimura Akinori
- 2021-05-07
Recruiting
- Phase III study of TH-004 in patients with postherpetic neuralgia
- Postherpetic neuralgia
- Arita Kazuhiro
- 2024-07-09
Recruiting
- A study to test long-term treatment with spesolimab in people with a skin condition disease called hidradenitis suppurativa (HS) who took part in a previous study with spesolimab
- Hidradenitis suppurativa
- Arita Takafumi
- 2024-05-10
Other
- Hepatitis B immunoglobulin plus Lamivudine to prevent recurrent hepatitis B following liver transplantation
- Liver transplant candidates with end-stage liver diseases due to hepatitis B.
- Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo
- 2009-03-05
Other
- A randomized non-inferiority trial of valganciclovir versus intravenous ganciclovir as preemptive therapy for cytomegalovirus infection in living donor liver transplantation.
- cytomegalovirus infection after living donor liver transplantation
- Artificial Organ and Transplantation Division, Tokyo University Hospital
- 2005-12-14
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Phase III clinical trial for AT-877 (i.v.) in patients with acute ischemic stroke. Placebo-controlled, double-blind add-on therapy to antiplatelet drugs
- Acute ischemic stroke (excluding cardioembolic stroke)
- Asahi Kasei Pharma Corporation
- 2007-07-02
Not yet recruiting
- Examination of the usefulness of angled bottles for establishing early oral feeding of preterm infants
- preterm infant
- Asai Hideyuki
- 2022-01-21